News

Published on 31 May 2021 on Insider Monkey via Yahoo Finance

Is Graybug Vision, Inc. (GRAY) A Good Stock To Buy?


Article preview image

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. In this article, we will take a closer look at hedge fund sentiment towards Graybug Vision, Inc. (NASDAQ:GRAY).

Is Graybug Vision, Inc. (NASDAQ:GRAY) a great investment right now? Money managers were taking a pessimistic view. The number of long hedge fund bets were trimmed by 2 recently. Graybug Vision, Inc. (NASDAQ:GRAY) was in 3 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 10. Our calculations also showed that GRAY isn't among the 30 most popular stocks among hedge funds (click for Q1 rankings).

Why do we pay any attention at all to hedge fund sentiment? Our research has shown that a select group of hedge fund holdings outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). That's why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to.

NASDAQ.GRAY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Individual investors are Graybug Vision, Inc.'s (NASDAQ:GRAY) biggest owners and were hit after...

Key Insights The considerable ownership by individual investors in Graybug Vision indicates that ...

Simply Wall St. via Yahoo Finance 20 Mar 2023

Graybug Vision Agrees To Merge With Inflammatory Disease-Focused Biopharma

Graybug Vision Inc (NASDAQ: GRAY) and CalciMedica Inc (CalciMedica) have announced a definitive m...

Benzinga via Yahoo Finance 22 Nov 2022

Graybug (GRAY) to Review Strategic Alternatives, Stock Up

Graybug Vision, Inc. GRAY announced that its board of directors is willing to conduct a comprehen...

Zacks via Yahoo Finance 29 Jun 2022

The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug,...

Here's a roundup of top developments in the biotech space over the last 24 hours: Eli Lilly And C...

Benzinga 11 Feb 2022

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations,...

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notc...

Benzinga 8 Nov 2021

Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial

Graybug Vision Inc (NASDAQ: GRAY) has provided a full-data analysis from the 18-month Phase 2b AL...

Benzinga via Yahoo Finance 2 Oct 2021

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks

Benzinga via Yahoo Finance 30 Sep 2021

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business,...

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here fo...

Benzinga via Yahoo Finance 29 Sep 2021

53 Biggest Movers From Friday

Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after ...

Benzinga via Yahoo Finance 9 Sep 2021

Is OFS Capital Corp (OFS) A Good Stock To Buy?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Secu...

Insider Monkey via Yahoo Finance 24 Jun 2021